Investigation of pulmonary involvement in inflammatory bowel disease in an experimental model of colitis |
Aydin, Bunyamin
(Division of Endocrinology and Metabolism, Department of Internal Medicine, Suleyman Demirel University Faculty of Medicine)
Songur, Yildiran (Division of Gastroenterology, Department of Internal Medicine, Memorial Hospital) Songur, Necla (Department of Chest Disease, Memorial Hospital) Aksu, Oguzhan (Division of Endocrinology and Metabolism, Department of Internal Medicine, Suleyman Demirel University Faculty of Medicine) Senol, Altug (Division of Gastroenterology, Department of Internal Medicine, Memorial Hospital) Ciris, I. Metin (Department of Pathology, Suleyman Demirel University Faculty of Medicine) Sutcu, Recep (Department of Clinical Biochemistry, Suleyman Demirel University Faculty of Medicine) |
1 | Su CG, Judge TA, Lichtenstein GR. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Clin North Am 2002;31:307-327. DOI |
2 | Kraft SC, Earle RH, Roesler M, Esterly JR. Unexplained bronchopulmonary disease with inflammatory bowel disease. Arch Intern Med 1976;136:454-459. DOI |
3 | Camus P, Piard F, Ashcroft T, Gal AA, Colby TV. The lung in inflammatory bowel disease. Medicine (Baltimore) 1993;72:151-183. DOI |
4 | Higenbottam T, Cochrane GM, Clark TJ, Turner D, Millis R, Seymour W. Bronchial disease in ulcerative colitis. Thorax 1980;35:581-585. DOI |
5 | Garg K, Lynch DA, Newell JD. Inflammatory airways disease in ulcerative colitis: CT and high-resolution CT features. J Thorac Imaging 1993;8:159-163. DOI |
6 | Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417-429. DOI |
7 | Sandborn WJ, Targan SR. Biologic therapy of inflammatory bowel disease. Gastroenterology 2002;122:1592-1608. DOI |
8 | Koutroubakis IE, Tsiolakidou G, Karmiris K, Kouroumalis EA. Role of angiogenesis in inflammatory bowel disease. Inflamm Bowel Dis 2006;12:515-523. DOI |
9 | Le Cras TD, Spitzmiller RE, Albertine KH, Greenberg JM, Whitsett JA, Akeson AL. VEGF causes pulmonary hemorrhage, hemosiderosis, and air space enlargement in neonatal mice. Am J Physiol Lung Cell Mol Physiol 2004;287:L134-L142. DOI |
10 | Songur N, Songur Y, Tuzun M, et al. Pulmonary function tests and high-resolution CT in the detection of pulmonary involvement in inflammatory bowel disease. J Clin Gastroenterol 2003;37:292-298. DOI |
11 | Mahadeva R, Walsh G, Flower CD, Shneerson JM. Clinical and radiological characteristics of lung disease in inflammatory bowel disease. Eur Respir J 2000;15:41-48. DOI |
12 | Marvisi M, Borrello PD, Brianti M, Fornarsari G, Marani G, Guariglia A. Changes in the carbon monoxide diffusing capacity of the lung in ulcerative colitis. Eur Respir J 2000;16:965-968. DOI |
13 | Fireman Z, Osipov A, Kivity S, et al. The use of induced sputum in the assessment of pulmonary involvement in Crohn’s disease. Am J Gastroenterol 2000;95:730-734. DOI |
14 | Kawada M, Arihiro A, Mizoguchi E. Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease. World J Gastroenterol 2007;13:5581-5593. DOI |
15 | Wallace JL, Keenan CM. An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis. Am J Physiol 1990;258(4 Pt 1):G527-G534. |
16 | Obermeier F, Kojouharoff G, Hans W, Scholmerich J, Gross V, Falk W. Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin Exp Immunol 1999;116:238-245. DOI |
17 | Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275. |
18 | Storch I, Sachar D, Katz S. Pulmonary manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2003;9:104-115. DOI |
19 | Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989;96:795-803. DOI |
20 | Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993;69:238-249. |
21 | Bewig B, Manske I, Bottcher H, Bastian A, Nitsche R, Folsch UR. Crohn's disease mimicking sarcoidosis in bronchoalveolar lavage. Respiration 1999;66:467-469. DOI |
22 | te Velde AA, Verstege MI, Hommes DW. Critical appraisal of the current practice in murine TNBS-induced colitis. Inflamm Bowel Dis 2006;12:995-999. DOI |
23 | Komai H, Naito Y, Okamura Y. Dextran sulfate as a leukocyte-endothelium adhesion molecule inhibitor of lung injury in pediatric open-heart surgery. Perfusion 2005;20:77-82. DOI |
24 | Hocking D, Ferro TJ, Johnson A. Dextran sulfate and heparin sulfate inhibit platelet-activating factor-induced pulmonary edema. J Appl Physiol (1985) 1992;72:179-185. DOI |
25 | Gursoy S, Guven K, Kula M, et al. Subclinical alveolar involvement in ulcerative colitis. Inflamm Bowel Dis 2005;11:372-375. DOI |
26 | Sandborn WJ, Hanauer SB. Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety. Inflamm Bowel Dis 1999;5:119-133. DOI |